These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10338107)

  • 1. The role of piracetam in the treatment of acute and chronic aphasia.
    Huber W
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
    Güngör L; Terzi M; Onar MK
    Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
    De Reuck J; Van Vleymen B
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
    Huber W; Willmes K; Poeck K; Van Vleymen B; Deberdt W
    Arch Phys Med Rehabil; 1997 Mar; 78(3):245-50. PubMed ID: 9084344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
    Enderby P; Broeckx J; Hospers W; Schildermans F; Deberdt W
    Clin Neuropharmacol; 1994 Aug; 17(4):320-31. PubMed ID: 9316679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
    De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
    Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of poststroke aphasia.
    Bakheit AM
    Expert Rev Neurother; 2004 Mar; 4(2):211-7. PubMed ID: 15853562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled study of donepezil in poststroke aphasia.
    Berthier ML; Green C; Higueras C; Fernández I; Hinojosa J; Martín MC
    Neurology; 2006 Nov; 67(9):1687-9. PubMed ID: 17101908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
    Kessler J; Thiel A; Karbe H; Heiss WD
    Stroke; 2000 Sep; 31(9):2112-6. PubMed ID: 10978039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 12. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
    Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
    Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study.
    Laska AC; von Arbin M; Kahan T; Hellblom A; Murray V
    Cerebrovasc Dis; 2005; 19(2):125-32. PubMed ID: 15644624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Zhang J; Wei R; Chen Z; Luo B
    CNS Drugs; 2016 Jul; 30(7):575-87. PubMed ID: 27236454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment for aphasia following stroke.
    Greener J; Enderby P; Whurr R
    Cochrane Database Syst Rev; 2001; 2001(4):CD000424. PubMed ID: 11687079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High scores on the Western Aphasia Battery correlate with good functional communication skills (as measured with the Communicative Effectiveness Index) in aphasic stroke patients.
    Bakheit AM; Carrington S; Griffiths S; Searle K
    Disabil Rehabil; 2005 Mar; 27(6):287-91. PubMed ID: 16040530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.